Capstone Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.97M Sell
138,470
-13,700
-9% -$276K 0.08% 284
2017
Q1
$2.61M Buy
152,170
+8,340
+6% +$145K 0.07% 324
2016
Q4
$2.58M Buy
143,830
+2,820
+2% +$51.1K 0.07% 316
2016
Q3
$2.93M Buy
141,010
+1,000
+0.7% +$24.8K 0.08% 286
2016
Q2
$3.77M Buy
140,010
+3,294
+2% +$90.3K 0.11% 209
2016
Q1
$3.7M Sell
136,716
-1,450
-1% -$38.8K 0.11% 245
2015
Q4
$4.01M Buy
138,166
+7,570
+6% +$210K 0.12% 218
2015
Q3
$3.54M Sell
130,596
-5,364
-4% -$152K 0.11% 229
2015
Q2
$3.72M Sell
135,960
-4,380
-3% -$123K 0.11% 241
2015
Q1
$3.75M Buy
140,340
+21,552
+18% +$496K 0.11% 241
2014
Q4
$2.51M Buy
118,788
+18,128
+18% +$405K 0.07% 312
2014
Q3
$2.4M Sell
100,660
-2,160
-2% -$49.7K 0.08% 285
2014
Q2
$2.38M Sell
102,820
-370
-0.4% -$8.17K 0.08% 301
2014
Q1
$2.35M Sell
103,190
-395,660
-79% -$8.43M 0.07% 321
2013
Q4
$1.84M Buy
498,850
+407,100
+444% +$7.09M 0.05% 398
2013
Q3
$1.55M Buy
91,750
+7,370
+9% +$124K 0.04% 553
2013
Q2
$1.31M Buy
+84,380
New +$1.4M 0.03% 590

Other funds holding NVO

Capstone Asset Management's NVO Position: Q2 2017 in Review

Capstone Asset Management reduced its Novo Nordisk (NVO) stake by 9% in Q2 2017, selling an estimated $276K and leaving 138,470 shares worth $2.97M. The position accounts for 0.08% of the portfolio, ranked #284.

Capstone Asset Management first reported a position in NVO in Q2 2013 and has held it in 17 quarters since. The position peaked at $4.01M in Q4 2015. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.

  • Capstone Asset Management held 138,470 shares of Novo Nordisk worth $2.97M as of Q2 2017.
  • Capstone Asset Management sold 13,700 Novo Nordisk shares in Q2 2017, an estimated $276K.
  • Novo Nordisk made up 0.08% of Capstone Asset Management's portfolio in Q2 2017, its #284 holding.
  • Capstone Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Novo Nordisk position peaked at $4.01M in Q4 2015.
  • 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.